Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Cardiovascular disease is "unacceptably" high and increasing among American adults ages 20 to 44, requiring aggressive prevention.
Read Full NewsPublished phase 3 data in JAMA Neurology highlighted tofersen's potential to slow ALS progression and improve survival, marking a breakthrough in SOD1-ALS treatment.
Adding CBT to Quetiapine Significantly Reduces Suicide Risk in Mood Disorders
Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia
FDA Requests Removal of Suicidal Ideation and Behavior Warning From GLP-1 RA Therapies
Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates
1.
It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.
2.
'Chemo brain' cognitive issues linked to poor lymphatic-system drainage
3.
Prostate cancer early detection system eliminates need for biopsy.
4.
Waist circumference outshines BMI as obesity-related cancer risk marker in men, but not women
5.
Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation
1.
Living with Shwachman-Diamond Syndrome: A Journey of Hope and Strength
2.
IGF2BP1 in Blood Disorders: Therapeutic Potential and Comprehensive Functional Insights
3.
Decoding the Failures in Acute Myeloid Leukemia Treatment: Mechanisms, Pathways, & Survival Outcomes
4.
Unlocking Immunity: TILs, Immunotherapy Biomarkers, and Toxicity Management in Oncology
5.
Introduction to Immune Thrombocytopenic Purpura
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
2.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
5.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge